Literature DB >> 17023054

Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.

Felix Gronen1, Klemens Ruprecht, Benedikt Weissbrich, Erdwine Klinker, Antje Kroner, Harald H Hofstetter, Peter Rieckmann.   

Abstract

The Epstein-Barr virus (EBV) has been implicated in the pathogenesis of multiple sclerosis (MS), however, the mechanisms by which EBV may be involved in MS are unknown. We here have investigated the frequency of EBV-specific cytotoxic T lymphocytes (CTL) in human leukocyte antigen (HLA)-B7(+) patients with MS and healthy controls using enzyme-linked immunospot assays and seven previously characterized HLA-B7-restricted immunogenic EBV peptides. Overall, there were no significant differences in the frequency of EBV-specific CTL between both groups. These data do not support the hypothesis that EBV could play a role in MS by inducing quantitatively altered EBV-specific CTL responses. Other pathogenic mechanisms for EBV in MS remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023054     DOI: 10.1016/j.jneuroim.2006.08.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  18 in total

Review 1.  Epstein-barr virus: environmental trigger of multiple sclerosis?

Authors:  Jan D Lünemann; Thomas Kamradt; Roland Martin; Christian Münz
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

Review 2.  Epstein-barr virus infection and multiple sclerosis: a review.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-06       Impact factor: 4.147

3.  Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers.

Authors:  Haseeb Ilias Basha; Venkataswarup Tiriveedhi; Timothy P Fleming; William E Gillanders; T Mohanakumar
Journal:  Breast Cancer Res Treat       Date:  2010-06-11       Impact factor: 4.872

Review 4.  [Multiple sclerosis and Epstein-Barr virus : new developments and perspectives].

Authors:  K Ruprecht
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

Review 5.  Epstein-Barr virus and multiple sclerosis.

Authors:  Jan D Lünemann; Christian Münz
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

6.  Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.

Authors:  Klemens Ruprecht; Felix Gronen; Marlies Sauter; Barbara Best; Peter Rieckmann; Nikolaus Mueller-Lantzsch
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

7.  Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.

Authors:  Mark H Fogg; Lori J Wirth; Marshall Posner; Fred Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

8.  Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.

Authors:  M P Pender; P A Csurhes; A Lenarczyk; C M M Pfluger; S R Burrows
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-11-17       Impact factor: 10.154

Review 9.  Is the risk of multiple sclerosis related to the 'biography' of the immune system?

Authors:  Bernd Krone; Frank Oeffner; John M Grange
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

10.  Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.

Authors:  Georg Laufer; Jens Mayer; Benedikt F Mueller; Nikolaus Mueller-Lantzsch; Klemens Ruprecht
Journal:  Retrovirology       Date:  2009-04-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.